Business Standard

Thursday, December 19, 2024 | 06:05 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Mavens Biotech net profit declines 44.44% in the June 2013 quarter

Image

Capital Market

Sales decline 1.14% to Rs 11.23 crore

Net profit of Mavens Biotech declined 44.44% to Rs 0.10 crore in the quarter ended June 2013 as against Rs 0.18 crore during the previous quarter ended June 2012. Sales declined 1.14% to Rs 11.23 crore in the quarter ended June 2013 as against Rs 11.36 crore during the previous quarter ended June 2012. ParticularsQuarter EndedJun. 2013Jun. 2012% Var.Sales11.2311.36 -1 OPM %1.072.02 -PBDT0.150.25 -40 PBT0.100.18 -44 NP0.100.18 -44

Powered by Capital Market - Live News

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Aug 19 2013 | 4:50 PM IST

Explore News